IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 23 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,879 | -37.9% | 180,382 | -13.3% | 0.00% | – |
| Q2 2023 | $668,033 | -46.5% | 208,110 | -13.6% | 0.00% | -100.0% |
| Q4 2022 | $1,247,660 | +37.6% | 240,980 | +6.0% | 0.00% | – |
| Q3 2022 | $907,000 | +13.2% | 227,299 | +17.1% | 0.00% | – |
| Q2 2022 | $801,000 | +11.6% | 194,164 | +38.2% | 0.00% | – |
| Q1 2022 | $718,000 | +47.7% | 140,454 | +62.7% | 0.00% | – |
| Q4 2021 | $486,000 | +57.3% | 86,309 | +86.4% | 0.00% | – |
| Q3 2021 | $309,000 | +8.4% | 46,299 | +2.4% | 0.00% | – |
| Q2 2021 | $285,000 | +213.2% | 45,224 | +543.8% | 0.00% | – |
| Q1 2021 | $91,000 | -7.1% | 7,024 | +19.1% | 0.00% | – |
| Q4 2020 | $98,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |